B. Riley Financial began coverage on shares of Strata Critical Medical (NASDAQ:SRTA – Get Free Report) in a research note issued on Wednesday. The brokerage set a “buy” rating and a $8.00 price target on the stock. B. Riley Financial’s price objective indicates a potential upside of 66.67% from the company’s previous close.
Strata Critical Medical Stock Performance
SRTA stock opened at $4.80 on Wednesday. Strata Critical Medical has a 1-year low of $2.35 and a 1-year high of $6.02. The company has a market capitalization of $414.56 million, a PE ratio of 9.80 and a beta of 2.05.
About Strata Critical Medical
Featured Stories
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
